公开(公告)号：US20210307693A1

公开(公告)日：2021-10-07

申请号：US17347327

申请日：2021-06-14

Applicant: DexCom, Inc.

Inventor： John Michael Gray ,  Jennifer Blackwell ,  Paul V. Neale ,  Justen Deering England ,  Andrew Joncich ,  Cameron Brock ,  Peter C. Simpson ,  Thomas Metzmaker ,  Neel Narayan Shah ,  Mark Douglas Kempkey ,  Patrick John Castagna ,  Warren Terry ,  Jason Halac ,  Christian Michael Andre George ,  Daniel E. Apacible ,  John Charles Barry ,  Maria Noel Brown Wells ,  Kenneth Pirondini ,  Andrew Michael Reinhardt ,  Jason C. Wong ,  Remy E. Gagnon ,  David DeRenzy ,  Randall Scott Koplin ,  Alan Baldwin ,  Young Woo Lee ,  David A. Keller ,  Louise Emma van den Heuvel ,  Carol Wood Sutherland

IPC: A61B5/00 ,  A61B5/145

Abstract: The present embodiments relate generally to applicators of on-skin sensor assemblies for measuring an analyte in a host, as well as their method of use and manufacture. In some aspects, an applicator for applying an on-skin sensor assembly to a skin of a host is provided. The applicator includes an applicator housing, a needle carrier assembly comprising an insertion element configured to insert a sensor of the on-skin sensor assembly into the skin of the host, a holder releasably coupled to the needle carrier assembly and configured to guide the on-skin sensor assembly while coupled to the needle carrier assembly, and a drive assembly configured to drive the insertion element from a proximal starting position to a distal insertion position, and from the distal insertion position to a proximal retraction position.

公开(公告)号：US20210290163A1

公开(公告)日：2021-09-23

申请号：US17165242

申请日：2021-02-02

Applicant: DexCom, Inc.

Inventor： Arthur Lin ,  Xianyan Wang ,  Pey-Jiun Ko

IPC: A61B5/00

Abstract: Examples of invasive biosensor alignment and retention features and methods are described. One example biosensor includes a housing comprising: a first surface defining a first opening, and a second surface opposite the first surface, the second surface defining a second opening, the first and second openings defining a substantially unobstructed pathway through the housing; a biosensor wire partially disposed within the housing and having an exterior portion extending through the first opening; a hollow insertion needle positioned within the pathway and extending through the first opening, the hollow insertion needle at least partially encircling the biosensor wire; and a biosensor retention feature collapsible against the first surface of the housing, the biosensor retention feature encircling and contacting the hollow insertion needle.

公开(公告)号：US20210275063A1

公开(公告)日：2021-09-09

申请号：US17156393

申请日：2021-01-22

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson ,  Jennifer Blackwell ,  Sebastian Bohm ,  Michael J. Estes ,  Jeff Jackson ,  Jason Mitchell ,  Jack Pryor ,  Daiting Rong ,  Sean T. Saint ,  Disha B. Sheth ,  Shanger Wang

IPC: A61B5/1473 ,  A61B5/145 ,  A61B5/00 ,  A61B17/34

Abstract: Sensor devices including dissolvable tissue-piercing tips are provided. The sensor devices can be used in conjunction with dissolvable needles configured for inserting the sensor devices into a host. Hardening agents for strengthening membranes on sensor devices are also provided. Methods of using and fabricating sensor devices are also provided.

公开(公告)号：US20210260288A1

公开(公告)日：2021-08-26

申请号：US17114190

申请日：2020-12-07

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Derek James Escobar ,  Sumitaka Mikami ,  Hari Hampapuram ,  Benjamin Elrod West ,  Nathanael Paul ,  Naresh C. Bhavaraju ,  Michael Robert Mensinger ,  Gary A. Morris ,  Andrew Attila Pal ,  Eli Reihman ,  Scott M. Belliveau ,  Katherine Yerre Koehler ,  Nicholas Polytaridis ,  Rian Draeger ,  Jorge Valdes ,  David Price ,  Peter C. Simpson ,  Edward Sweeney

IPC: A61M5/172 ,  G16H20/17 ,  G16H40/67 ,  G16H50/30 ,  G16H50/20 ,  G16H10/60 ,  H04W12/033

Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.

公开(公告)号：US20210259591A1

公开(公告)日：2021-08-26

申请号：US17114254

申请日：2020-12-07

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Derek James Escobar ,  Sumitaka Mikami ,  Hari Hampapuram ,  Benjamin Elrod West ,  Nathanael Paul ,  Naresh C. Bhavaraju ,  Michael Robert Mensinger ,  Gary A. Morris ,  Andrew Attila Pal ,  Eli Reihman ,  Scott M. Belliveau ,  Katherine Yerre Koehler ,  Nicholas Polytaridis ,  Rian Draeger ,  Jorge Valdes ,  David Price ,  Peter C. Simpson ,  Edward Sweeney

IPC: A61B5/145 ,  A61B5/00 ,  A61M5/172 ,  A61M5/142

Abstract: Machine learning in an artificial pancreas is described. An artificial pancreas system may include a wearable glucose monitoring device, an insulin delivery system, and a computing device. Broadly speaking, the wearable glucose monitoring device provides glucose measurements of a person continuously. The artificial pancreas algorithm, which may be implemented at the computing device, determines doses of insulin to deliver to the person based on a variety of aspects for the purpose of maintaining the person's glucose within a target range, as indicated by those glucose measurements. The insulin delivery system then delivers those determined doses to the person. As the artificial pancreas algorithm determines insulin doses for the person over time and effectiveness of the insulin doses to maintain the person's glucose level in the target range is observed, an underlying model of the artificial pancreas algorithm may be updated to better determine insulin doses.

公开(公告)号：US20210251533A1

公开(公告)日：2021-08-19

申请号：US17246500

申请日：2021-04-30

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson ,  James H. Brauker ,  Mark C. Brister ,  Paul V. Goode, JR. ,  Apurv Ullas Kamath ,  Aarthi Mahalingam ,  Jack Pryor ,  Matthew D. Wightlin

IPC: A61B5/145 ,  A61B5/1473 ,  A61B5/1486 ,  A61B5/00 ,  A61B5/1495 ,  A61B5/15 ,  A61B5/05 ,  A61B17/34

Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

公开(公告)号：USD926325S1

公开(公告)日：2021-07-27

申请号：US29717217

申请日：2019-12-16

Applicant: DexCom, Inc.

Designer： John Charles Barry ,  Young Woo Lee ,  David A. Keller ,  Louise Emma van den Heuvel ,  Carol Wood Sutherland ,  John Stanley Hayes

公开(公告)号：US11055198B2

公开(公告)日：2021-07-06

申请号：US16728536

申请日：2019-12-27

Applicant: DexCom, Inc.

Inventor： Issa Sami Salameh ,  Douglas William Burnette ,  Tifo Vu Hoang ,  Steven David King ,  Stephen M. Madigan ,  Michael Robert Mensinger ,  Andrew Attila Pal ,  Michael Ranen Tyler

IPC: G06F11/36 ,  G06F8/71 ,  G06F8/70 ,  G06F11/14 ,  G06F11/00 ,  G06F9/445 ,  G16H40/40 ,  H04W88/02 ,  A61B5/145 ,  H04W4/70 ,  H04L29/08 ,  H04W4/20 ,  H04M1/724 ,  G06F8/65 ,  H04W4/12 ,  A61B5/00 ,  H04M1/72403

Abstract: Disclosed are systems, methods, and articles for determining compatibility of a mobile application and operating system on a mobile device. In some aspects, a method includes receiving one or more data values from a mobile device having a mobile medical software application installed thereon, the data value(s) characterizing a version of the software application, a version of an operating system installed on the mobile device, and one or more attributes of the mobile device; determining whether the mobile medical software application is compatible with the operating system by at least comparing the received data value(s) to one or more test values in a configuration file; and sending a message to the mobile device based on the determining, the message causing the software application to operate in one or more of a normal mode, a safe mode, and a non-operational mode.

公开(公告)号：US20210196163A1

公开(公告)日：2021-07-01

申请号：US17200620

申请日：2021-03-12

Applicant: DexCom, Inc.

Inventor： Jason Halac ,  John Michael Gray ,  Neal Davis Johnston ,  Justen Deering England ,  Peter C. Simpson ,  Paul V. Neale ,  Jennifer Blackwell ,  Maria Noel Brown Wells ,  Kenneth Pirondini ,  Andrew Michael Reinhardt ,  Mark Douglas Kempkey

IPC: A61B5/1486 ,  A61B5/00 ,  A61B5/145

Abstract: Systems for applying a transcutaneous monitor to a person can include a telescoping assembly, a sensor, and a base with adhesive to couple the sensor to skin. The sensor can be located within the telescoping assembly while the base protrudes from a distal end of the system. The system can be configured to couple the sensor to the base by compressing the telescoping assembly.

公开(公告)号：US20210186383A1

公开(公告)日：2021-06-24

申请号：US17132664

申请日：2020-12-23

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson ,  Ying Li ,  Apurv Ullas Kamath ,  Richard C. Yang

IPC: A61B5/1495 ,  A61B5/145 ,  A61B5/00 ,  A61M5/172

Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.